MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Tempus AI, Inc.

< Previous 1 2 Next >
Tempus Announces 18 Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus to Report First Quarter 2025 Financial Results on May 6
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus Signs Expanded Strategic Agreements with AstraZeneca and Pathos to Develop the Largest Multimodal Foundation Model in Oncology
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus Unveils Advisory Board Featuring Leading Physicians From Across the U.S.
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus to Present at the 24th Annual Needham Virtual Healthcare Conference
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus Announces Acquisition of Deep 6 AI
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus Reports Fourth Quarter and Full Year 2024 Results
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus to Present at TD Cowen's 45th Annual Health Care Conference
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus to Participate in the Morgan Stanley Technology, Media and Telecom Conference
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus Announces Collaboration with IFLI Aimed at Supporting Development of Targeted Therapies for Follicular Lymphoma
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus to Report Fourth Quarter and Full Year 2024 Financial Results on February 24
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus Completes Acquisition of Ambry Genetics
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus Announces National Launch of olivia, its AI-enabled Personal Health Concierge App for Patients
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus Announces the National Launch of FDA-Approved xT CDx Test
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus One Introduces New GenAI Capabilities to Query Millions of Unstructured Documents for Research and Clinical Care
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus Announces Its First-Ever, Whole-Genome Sequencing Assay, xH
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus Announces Preliminary Fourth Quarter and Full Year 2024 Results
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus Announces a Collaboration With Genialis to Develop RNA-Based Biomarker Algorithms
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus to Present at 43rd Annual J.P. Morgan Healthcare Conference
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
New CMS Decision Provides Medicare Coverage for the Clinical Use of the Tempus ECG-AF Device
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus to Participate in the Piper Sandler 36th Annual Healthcare Conference
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus Molecular Profiling Integration Now Available Through Flatiron’s OncoEMR®
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer Care
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus Announces Nine Abstracts Accepted for Presentation at the 2024 Society for Immunotherapy of Cancer Annual Meeting
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus Announces the Clinical Launch of its Immune Profile Score Algorithmic Test
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus Reports Third Quarter 2024 Results and Agreement to Acquire Ambry Genetics
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus to Report Third Quarter 2024 Financial Results on November 4
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
Tempus Announces Collaboration With JW Pharmaceutical to Apply Real-World Data and Biological Modeling to Enhance Early Research and Development
From Tempus AI, Inc.
Via Business Wire
Tempus to Report Third Quarter 2024 Financial Results on November 7
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
TOP
Email a Story